Table 1 Patient characteristics
From: Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis
Characteristics | Tonsillar hypertrophy n = 47 | Recurrent tonsillitis n = 42 | P value |
|---|---|---|---|
Age, years (range) | 8 (2, 46) | 20 (7, 60) | < 0.0001 |
Male | 27 (57%) | 23 (55%) | 0.80 |
Tonsillectomy and adenotomy | 28 (60%) | 5 (12%) | < 0.0001 |
Self-reported allergy | 20/43 (47%) | 23/40 (58%) | 0.32 |
Food | 6/43 (14%) | 3/39 (8%) | 0.38 |
Drug | 4/43 (9%) | 4/39 (10%) | 0.87 |
Seasonal, i.e. pollen | 0/43 (0%) | 7/39 (18%) | 0.004 |
Perennial, i.e. animal or house dust mite | 3/43 (7%) | 2/39 (5%) | 0.74 |
Other | 2/43 (5%) | 2/39 (5%) | 0.90 |
Multiple | 5/43 (12%) | 4/39 (10%) | 0.86 |
Physician-diagnosed atopic dermatitis | 11/44 (25%) | 4/38 (11%) | 0.09 |
Self-reported allergic rhinitis | 11/44 (25%) | 11/39 (28%) | 0.74 |
Physician-diagnosed asthma | 6/42 (14%) | 6/39 (15%) | 0.89 |
Self-smoking | 2/43 (5%) | 14/40 (35%) | 0.0005 |
Maternal smoking | 15/44 (34%) | 13/41 (32%) | 0.82 |
Paternal smoking | 16/41 (39%) | 19/36 (53%) | 0.23 |
Season of the surgery | 0.85 | ||
Winter (months 12–2) | 7 (15%) | 4 (10%) | |
Spring (months 3–5) | 14 (30%) | 13 (31%) | |
Summer (months 6–8) | 8 (17%) | 5 (12%) | |
Fall (months 9–11) | 18 (38%) | 20 (48%) | |
Respiratory symptoms | |||
The operation day | 6/39 (15%) | 7/38 (18%) | 0.72 |
Within 2 weeks | 16/42 (38%) | 12/37 (32%) | 0.60 |
Within 4 weeks | 23/42 (55%) | 18/37 (48%) | 0.59 |
One month prior the operation | |||
Throat pain | 8/39 (21%) | 14/35 (40%) | 0.0005 |
Rhinitis | 23/39 (59%) | 6/35 (17%) | 0.0002 |
Cough | 15/39 (38%) | 5/36 (14%) | 0.02 |
Acute otitis media | 2/39 (5%) | 0/35 (0%) | 0.17 |
Wheezing | 2/39 (5%) | 0/35 (0%) | 0.17 |
25(OH)D level | |||
Total (nmol/l) | 56.2 (41.7, 66.9) | 45.7 (34.4, 72.3) | 0.08 |
Free (pg/ml) | 6.4 (4.9, 8.1) | 5.0 (3.3, 8.8) | 0.14 |
Bioavailable (ng/ml) | 2.2 (1.7, 2.9) | 1.6 (1.1, 2.7) | 0.01 |